Ultrasonic equipment gross margin increase import share has dropped!

With the introduction of domestic ultrasound taps new high-end equipment, once regarded as a "no-go zone" of the third-level hospital channel gradually broke the ice.
, Kaiser Medical released its 2017 half-yearly report, and the company's operating income for the January-June period was RMB424 million, up 64.05 percent year-on-year, and net profit attributable to parents was RMB73.65 million, up 120.62 percent year-on-year.
said that thanks to last year's high-end color super S50 to the market, high gross margin products growth of more than 600%. Compared with the lower end of the product, S50 gross margin is 10%-15%, as the product continues to release and proportion increased, color super gross margin increased from 68.97 percent at the end of last year to 71.69 percent.
was established in 2002, completed the stock reform at the end of 2014, and landed on the GEM on April 6, 2017. Its main business for the development and manufacture of clinical medical equipment, products covering ultrasound diagnostic systems, electronic endoscopy systems, in-body diagnostic systems, in the field of ultrasound diagnostics, products cover almost all suitable for ultrasound imaging diagnostics in the medical field.
medical institutions and brokerages believe that, in addition to the ultra-high-end market, the import of domestic ultrasound equipment will accelerate the process of substitution.gross margin of
in recent years, with the continuous progress of research and development, the gross margin of ultrasonic products further increased.
technology of "ultrasound" lies in the performance of ultrasonic probes. In clinical practice, the ultrasound probes required for different scenes are different, and the requirements for detection range, sensitivity and clarity are also different. "Wuhan One-Three-A Hospital color super-diagnosis room head believes that whether the probe meets the clinical needs, is the gap between domestic and imported brands.
medical prospectus shows that the S50, which was developed and approved by the company, basically meets the HD standard in image clarity and can meet more than 90% of the needs of clinical departments. Because it has a variety of probes. Among them, the single crystal probe basically reached the ultrasonic three major GENERAL Electric, Philips, Siemens technology level.
technological breakthroughs are evident at one end of the gross margin. Public data show that the gross margin of open medical ultrasound products increased from 57.9% in 2012 to 65.0% in 2016, and the gross margin of the S50 increased to 69.2% in 2017.
, a rival, is cutting costs by gradually shifting production from Zonare, an overseas company it acquired in 2013, to its China headquarters. Its gross margin for medical imaging products from 2014 to 2016 was 65.06%, 65.27% and 68.54%, respectively.
this, Tianfeng Securities Pharmaceutical Industry Research Team said in a research report that the S50 and Myer's DC-8/R7 are the same high-end products, is the most important battleground for import substitution. The terminal market mainly includes township hospitals, private hospitals, triple-A hospitals in the "work machine" and so on, this part of the customer clinical demand, high sensitivity to machine prices, because the price of imported instruments than the same grade 20%-30%, so it has been widely recognized by the market.domestic brand market is huge
the future growth space of domestic ultrasound equipment is still huge.
IHS, the global market for medical ultrasound diagnostic equipment was about $6.2 billion in 2014 and is expected to reach $7.4 billion in 2019. China's growth rate is even faster, with the market for ultrasound diagnostic equipment reaching 6.9 billion yuan in 2014 and expected to reach 9.1 billion yuan in 2019.
" ultrasound diagnostic devices were initially monopolized by foreign brands, with GM, Philips and Siemens accounting for almost all of the market share. "The above-mentioned color super-diagnosis room head told the 21st century economic reporter, from 2004 the first domestic color super-launched, after more than ten years of development, domestic color super gradually from the low end to the high-end market, "Kai li, Meirui and other domestic manufacturers in recent years have developed high-end products, squeezing the market space of imported brands, the current market share of imported brands has dropped to 70%."
as the domestic ultrasound products two leading, Murray and Kaili in the past few years experienced a period of steady growth. According to the Meirui Medical Prospects, the revenue of medical imaging products from 2014 to 2016 was RMB21,987.41 million, RMB22,309.421 million and RMB23,543.393 million, respectively. The average proportion of color super products in 2012-2016 was 82.2%, and the main business revenue increased from 484 million yuan in 2012 to 719 million yuan in 2016, with a compound annual growth rate of 10.4%.
between the first liter and one drop, the industry technical barriers gradually pushed down, domestic brands will further enhance market share.
2016, the growth of ultrasonic domestic leaders has significantly outstried the growth of imported brands and exceeded the industry average. "The above-mentioned Tianfeng Securities Research Report believes that, with the continuous implementation of control fees, domestic equipment with excellent cost-effective gradually crowding out the share of imported brands, especially in the amount of equipment, has a great competitive advantage.on the one hand,
China's ultrasound market customers are major hospitals and medical institutions, the unique hospital classification system results in uneven distribution of medical resources; The head of the above-mentioned color super-diagnosis and treatment room said that under the joint action of the two factors, the domestic color super and imported products formed a differentiated competitive pattern.
the person in charge further explained that the three-tier hospital has high income and adequate medical funds, so it has become the main sales channel for imported ultrasound products. While domestic ultrasound is relatively cheap, import replacement objects are mainly high-grade hospitals and low-grade hospitals, medium-level hospitals are more willing to purchase imports, because it is easier to operate, but also more durable.
stage of domestic equipment and imported high-end models still exist gap, reflected in algorithms, materials, clinical cognition and other details of the depth of optimization. "Imported high-end models can assist doctors in completing some basic functional diagnosis and data analysis, such as ultra-high-end heart color super in addition to two-dimensional imaging, but also on this basis to analyze the myocardial movement, cardiac infarction state, myocardial function decline and other processes." The head of the above-mentioned color super-diagnosis and treatment room said that sanjia hospital needs to undertake part of the scientific research tasks, often on the model accuracy requirements are higher, so the import of high-end models become the first choice.
Tianfeng Securities Research Report believes that the import substitution trend in the field of ultrasonic medical devices is irreversible, but the length of time, depending on the development of clinical medicine, the understanding and accumulation of demand, supporting equipment and enterprise development, industrial level and other factors. In the future, domestic brands will continue to seize the import market share, imported brands can only retain ultra-high-end and specific ultrasound detection market, to meet the specific needs of doctors scientific research and clinical, other market share is expected to be replaced by excellent domestic brands. (21st Century Economic Report)